CRBX Stock Overview
Carbiotix AB (publ), a biotechnology company develops health testing and microbiome modulators to address a range of chronic and metabolic diseases.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Carbiotix AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.065 |
| 52 Week High | kr3.28 |
| 52 Week Low | kr0.05 |
| Beta | 0.96 |
| 1 Month Change | -30.11% |
| 3 Month Change | -76.01% |
| 1 Year Change | -97.99% |
| 3 Year Change | -99.55% |
| 5 Year Change | n/a |
| Change since IPO | -98.75% |
Recent News & Updates
Shareholder Returns
| CRBX | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 8.0% | -0.1% | -0.7% |
| 1Y | -98.0% | -7.8% | 8.8% |
Return vs Industry: CRBX underperformed the Swedish Medical Equipment industry which returned -7.8% over the past year.
Return vs Market: CRBX underperformed the Swedish Market which returned 8.8% over the past year.
Price Volatility
| CRBX volatility | |
|---|---|
| CRBX Average Weekly Movement | 24.2% |
| Medical Equipment Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in SE Market | 13.2% |
| 10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: CRBX's share price has been volatile over the past 3 months.
Volatility Over Time: CRBX's weekly volatility (24%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 10 | Erik Deaner | carbiotix.com |
Carbiotix AB (publ), a biotechnology company develops health testing and microbiome modulators to address a range of chronic and metabolic diseases. Its portfolio includes prebiotic ingredients and diagnostic testing services. The company develops CarbiAXOS, a second-generation prebiotic soluble fiber based on virgin and upcycled natural substrates containing arabinoxylo-oligosaccharides that is customized to meet customer needs to the production of short chain fatty acids or any other effect; and LinkGut, a health test.
Carbiotix AB (publ) Fundamentals Summary
| CRBX fundamental statistics | |
|---|---|
| Market cap | kr11.71m |
| Earnings (TTM) | -kr13.48m |
| Revenue (TTM) | kr4.29m |
2.7x
P/S Ratio-0.9x
P/E RatioIs CRBX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CRBX income statement (TTM) | |
|---|---|
| Revenue | kr4.29m |
| Cost of Revenue | kr842.88k |
| Gross Profit | kr3.45m |
| Other Expenses | kr16.93m |
| Earnings | -kr13.48m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
| Earnings per share (EPS) | -0.075 |
| Gross Margin | 80.37% |
| Net Profit Margin | -313.95% |
| Debt/Equity Ratio | 0% |
How did CRBX perform over the long term?
See historical performance and comparison